Loading...

kneat.com, inc.

KSIOFPNK
Healthcare
Medical - Healthcare Information Services
$4.11
$0.21(5.38%)

kneat.com, inc. (KSIOF) Financial Performance & Income Statement Overview

Review kneat.com, inc. (KSIOF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
43.00%
43.00%
Operating Income Growth
56.06%
56.06%
Net Income Growth
45.27%
45.27%
Operating Cash Flow Growth
867.57%
867.57%
Operating Margin
-11.41%
11.41%
Gross Margin
75.35%
75.35%
Net Profit Margin
0.84%
0.84%
ROE
0.83%
0.83%
ROIC
-7.13%
7.13%

kneat.com, inc. (KSIOF) Income Statement & Financial Overview

Explore comprehensive income reports for kneat.com, inc. KSIOF, broken down by year and quarter.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$14.75M$13.73M$12.76M$11.68M
Cost of Revenue$3.82M$3.37M$2.99M$2.98M
Gross Profit$10.92M$10.36M$9.77M$8.69M
Gross Profit Ratio$0.74$0.75$0.77$0.74
R&D Expenses$4.70M$4.55M$3.92M$4.76M
SG&A Expenses$7.63M$6.65M$6.08M$6.56M
Operating Expenses$12.33M$11.20M$10.00M$11.33M
Total Costs & Expenses$16.15M$14.57M$12.99M$14.31M
Interest Income$198639.00$298309.00$172005.00$173000.00
Interest Expense$888545.00$1.03M$892318.00$870905.00
Depreciation & Amortization$3.02M$2.92M$2.32M$2.88M
EBITDA$6.08M$1.55M$4.47M$678561.00
EBITDA Ratio$0.41$0.11$0.35$0.06
Operating Income-$1.40M-$836880.00-$228918.00-$2.63M
Operating Income Ratio-$0.10-$0.06-$0.02-$0.23
Other Income/Expenses (Net)$3.57M-$1.56M$1.49M-$439857.00
Income Before Tax$2.17M-$2.40M$1.26M-$3.07M
Income Before Tax Ratio$0.15-$0.17$0.10-$0.26
Income Tax Expense$24430.00$61906.00$86253.00$28553.00
Net Income$2.15M-$2.46M$1.17M-$3.10M
Net Income Ratio$0.15-$0.18$0.09-$0.27
EPS$0.02-$0.03$0.01-$0.04
Diluted EPS$0.02-$0.03$0.01-$0.04
Weighted Avg Shares Outstanding$94.22M$93.92M$85.92M$85.58M
Weighted Avg Shares Outstanding (Diluted)$97.74M$93.92M$85.92M$85.58M

Financial performance has remained strong, with revenue growing from $11.68M in Q2 2024 to $14.75M in Q1 2025. Gross profit continued to perform well, with margins at 74% in the latest quarter. Operating income reached -$1.40M in Q1 2025, holding a steady -10% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $6.08M. Net income rose to $2.15M, keeping EPS at $0.02. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;